A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments.
Source: New York Times
A ‘Game Changer’ for Patients With Esophageal Cancer
Published in Alcoholic Beverages, Bristol Myers Squibb Company, Cancer, Chemotherapy, Clinical Trials, Drugs (Pharmaceuticals), East Asia, Esophageal Cancer, New England Journal of Medicine, Radiation and United States
More from Alcoholic BeveragesMore posts in Alcoholic Beverages »
- Albany Story: Drinks to Go, the Pandemic and Lobbyists
- As New York Revisits To-Go Drink, Liquor Stores Prepare for Battle
- Dining Sheds Saved N.Y.C. Could They Destroy It?
- The Abrupt Halt of To-Go Cocktails Leaves New York Restaurants Reeling
- N.Y. State of Emergency Ends Thursday. Booze to Go to End With It.
More from CancerMore posts in Cancer »
More from Clinical TrialsMore posts in Clinical Trials »
- Why a Century-Old Vaccine Offers New Hope Against Pathogens
- Why Monkeypox Vaccine Shortage May Threaten the Immunocompromised
- Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions
- A Better Way to Measure Immunity in Children
- New Drug Slashed Deaths Among Patients With Severe Covid, Maker Claims
More from Drugs (Pharmaceuticals)More posts in Drugs (Pharmaceuticals) »
More from New England Journal of MedicineMore posts in New England Journal of Medicine »
More from United StatesMore posts in United States »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Long Covid Has Played Role in More Than 3,500 Deaths in US, CDC Says
- Hometown of Tyler Adams, U.S. Captain, Still Proud Even With Loss
- Judge Criticizes D.A. for Halting Prosecution of Woman in Husband’s Death
- New York Philharmonic Was Once All-Male. Now, Women Outnumber Men.
Be First to Comment